An independent safety review conducted during what was referred to as a ‘routine action’ to maintain the ‘integrity of the trials’ ended Saturday.
Your email address will not be published. Required fields are marked *
Comment
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Δ
